[{"Assets_0_Q3_USD":310192000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-121479000.0,"NetIncomeLoss_1_Q3_USD":-27512000.0,"NetIncomeLoss_3_Q3_USD":-104293000.0,"StockholdersEquity_0_Q3_USD":-29401000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]